Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study
布地奈德/格隆溴铵/福莫特罗治疗慢性阻塞性肺疾病的ETHOS试验显示全因死亡率降低。一项随机、双盲、多中心、平行组研究
期刊:American Journal of Respiratory and Critical Care Medicine
影响因子:19.4
doi:10.1164/rccm.202006-2618OC
Martinez, Fernando J; Rabe, Klaus F; Ferguson, Gary T; Wedzicha, Jadwiga A; Singh, Dave; Wang, Chen; Rossman, Kimberly; St Rose, Earl; Trivedi, Roopa; Ballal, Shaila; Darken, Patrick; Aurivillius, Magnus; Reisner, Colin; Dorinsky, Paul